Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
The deal is AbbVie’s latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
The deal is AbbVie’s latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender